US Stock MarketDetailed Quotes

BCAB BioAtla

Watchlist
  • 0.4397
  • -0.0009-0.20%
Trading Apr 28 14:30 ET
25.68MMarket Cap-0.31P/E (TTM)

About BioAtla Company

BioAtla, Inc. engages in the development of novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its CAB portfolio include MABs & ADCS, BA3011, and BA3021. The company was founded by Jay M. Short and Carolyn Anderson in March 2007 and is headquartered in San Diego, CA.

Company Profile

SymbolBCAB
Company NameBioAtla
Listing DateDec 16, 2020
Issue Price18.00
Founded2007
CEODr. Jay M. Short,PhD
MarketNASDAQ
Employees61
Fiscal Year Ends12-31
Address11085 Torreyana Road
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-558-0708

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay M. Short,PhD
  • Chairman of the Board and Chief Executive Officer
  • 1.95M
  • Richard A. Waldron
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • 881.70K
  • Christian Vasquez
  • Chief Accounting Officer, Controller and Corporate Secretary
  • --
  • Dr. Eric Sievers, M.D.
  • Chief Medical Officer
  • 961.08K
  • Scott A. Smith
  • Director
  • 65.91K
  • Professor Lawrence J. Steinman, M.D.
  • Lead Independent Director
  • 89.96K
  • Sylvia McBrinn
  • Independent Director
  • 83.41K
  • Edward Williams
  • Independent Director
  • 61.53K
  • Dr. Susan Moran, M.D.
  • Independent Director
  • 74.91K
  • Dr. Mary Ann Gray,PhD
  • Independent Director
  • 70.16K

Market Insights

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.